References

• 2006Hot Markets, Investor Sentiment, and IPO Pricing*689 cited
• 2004Initial Public Offerings in Hot and Cold Markets408 cited
• 2014The JOBS Act and IPO volume: Evidence that disclosure costs affect the IPO decision224 cited
• 2008Cycles in the IPO market☆217 cited
• 2021Immunizing markets against the pandemic: COVID-19 vaccinations and stock volatility around the world139 cited
• 2005The Valuation of Biotech IPOs133 cited
• 2014Life expectancy and economic growth105 cited
• 2021The impact of COVID-19 shocks on the volatility of stock markets in technologically advanced countries51 cited
• 2019The effects of stricter regulation on the going public decision of small and knowledge‐intensive firms25 cited
• 2007Determinants of Idiosyncratic Volatility for Biotech IPO Firms23 cited
• 2018The impact of stakeholders’ temporal orientaton on short- and long-term IPO outcomes: A meta-analysis21 cited
• 2006Underwriter learning about unfamiliar firms: Evidence from the history of biotech IPOS17 cited
• 2021Life sciences intellectual property licensing at the Massachusetts Institute of Technology16 cited

Cited by

No citing works inside the corpus for this window.